Reported about 4 hours ago
CoreWeave's ambitious $5 billion acquisition of Core Scientific is under threat as major shareholders oppose the deal, arguing that the valuation calculations have changed unfavorably. The September offer of $20.40 per share is now perceived as closer to $17 due to recent market shifts, leading to resistance from key investors. While CoreWeave maintains its stance on the current terms, the situation poses a risk to its stock value and the broader AI infrastructure market if the merger collapses.
Source: YAHOO